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Evaluations of telemedicine have sought to assess various measures of effectiveness
(e.g., diagnostic accuracy), efficiency (e.g., cost), and engagement (e.g., patient
satisfaction) to determine its success. Few studies, however, have looked at evaluating the
organizational impact of telemedicine, which involves technology and process changes
that affect the way that it is used and accepted by patients and clinicians alike. This study
reviews and discusses the conceptual issues in telemedicine research and proposes a
fresh approach for evaluating telemedicine. First, we advance a patient pathway
perspective, as most of the existing studies view telemedicine as a support to a singular
rather than multiple aspects of a health care process. Second, to conceptualize patient
pathways and understand how telemedicine impacts upon them, we propose simulation
as a tool to enhance understanding of the traditional and telemedicine patient pathway.
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The telemedicine evaluation literature has grown substan-
tially from the advancement of a specific framework for
assessing telemedicine by the Institute of Medicine (IOM)
(16). This early report identified five dimensions important
to evaluating telemedicine: quality, access, cost, patient per-
ceptions, and clinician perceptions. However, a more recent
report by The Lewin Group (27) both confirmed and extended
these evaluation dimensions. It considered the properties of
these dimensions, in terms of measures and their impacts, but
also the methodology issues involved in evaluation. This di-
rectly responded to some disquiet expressed in the literature
over rigor and consistency that limited the generalizability of
some studies’ findings. In light of these concerns, we discuss
two possible improvements for telemedicine evaluation.
First, we argue that the focus of the evaluation itself
should be widened to look at telemedicine in the context
of the patient pathway (also known in the literature as the
clinical pathway) to understand its place along the patient’s
journey through the health service. Second, we put forward
simulation as a tool for evaluating telemedicine through its
representation of the patient pathway. Simulation will be
discussed as a viable methodology for addressing some of the
weaknesses documented in telemedicine evaluation, through
a review of the measures and methodologies used in the
assessment of telemedicine. The discussion of the potential
benefits of simulating patient pathways is supported by an
illustration—using leg ulcer sufferers as a case example—to
contribute to an understanding of care delivery by traditional
and telemedicine processes.
TELEMEDICINE EVALUATION ISSUES
Measures
Reviews of telemedicine evaluation are limited (1;12;25;27),
but those that do exist provide important overviews as to the
status of evaluations in terms of the measures and method-
ology used to assess telemedicine. Most evaluations have
sought to assess various quantitative measures of effective-
ness (e.g., diagnostic accuracy), efficiency (e.g., cost), and
engagement (e.g., patient satisfaction) to determine its suc-
cess. However, these studies have tended to focus on single
clinical contexts, specialties, and measures. To highlight the
problematic issues around the measures currently assessed
in telemedicine evaluation, we will briefly focus on three key
evaluation measures: (i) Diagnostic accuracy—this measure
has tended to overly dominate many studies’ outcomes (1);
(ii) Cost (and its associated variables, e.g., benefit, utility,
and so on)—many studies have equated a cost-saving as a
benefit, but with no reference to how it affects clinical out-
comes (28); and (iii) Patient satisfaction—this measure is the
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Table 1. Key Evaluation Methodology Issues for Telemedicine
Methodological Approach
Evaluation methodology issue Current telemedicine evaluations Simulation
Technological maturity
Progress of technology through its
lifecycle and the stage of evaluation
Often carried out as single case studies
of performance at too early or late a
stage and can often produce unduly
positive or negative findings (26)
Evaluates telemedicine along the
continuum of maturity from immature
prototypes to fully matured working
systems
Focus of evaluation
Scope of the evaluation from the
technology itself to its broader
context
The focus is predominantly placed on
the specifics of the technology itself,
as opposed to its organizational
impact (2).
Offers a more holistic approach, in
analysing the processes of care into
which telemedicine is situated, along
with key evaluation measures
Perspective of evaluation
Standpoint from which the benefits
of the technology are realized
A single perspective analysis is most
common, often to the point of
exclusion of the impact from an
alternative perspective (21)
Provides a multi-perspective analysis,
(depending on the model’s variables),
e.g., to reflect a patient/clinician view
Comparator
Definition of a suitable control group
with which to gauge the effect of the
technology’s intervention
Patients who are treated with and
without telemedicine and then
compared, are often not of a similar
level (8)
Allows a consistent way of performing
like-with-like comparisons as data from
a single set of patients can be run in both
the traditional and telemedicine models
Randomization
Assigning of participants to
experimental and control groups on a
random basis
This process is difficult to achieve as the
sample group in a study are generally
quite small, in some published cases
as few as ten patients (20)
Avoids randomization issues because a
single set of patients can be run in both
the traditional and telemedicine models
Time horizon
Duration of data collection in a study The focus has been on short-term pilot
projects, with a lack of follow-up (5)
Predicts future outcomes, applying the
analysis to gauge the long-term effects of
telemedicine implementation
most common evaluation undertaken, tends to produce con-
sistently positive results, but can often be misleading, as
patient satisfaction measures often fail to go beyond first
impressions (19).
A major reason for some of the limitations cited in the
research is that few high-quality studies exist (15). Despite
the usefulness of the clinical and economic data that have
been produced, the methodological paucity in the research
has somewhat undermined the value of the assessments un-
dertaken. This finding has resulted in calls for patients and
practitioners alike to remain skeptical over the professed
benefits of telemedicine compared with traditional face-to-
face patient care (12). In an attempt to manage some of the
methodological issues in telemedicine evaluation, simulation
is proposed as a potentially useful tool for producing more
robust findings.
Methodology
As a methodological approach, simulation revolves around
creating computer models of social structures and processes.
These models are subject to “simulation” that is experimen-
tation through the manipulation of variables (e.g., time and
cost) to understand the behavior of the model and evaluate
the extent to which it provides an accurate account of the
behavior of the observed system (13). In health care, simu-
lation has achieved some success as a problem-solving tool
(3). Moreover, as well as being able to incorporate the afore-
mentioned evaluation measures, it will be posited that simu-
lation modeling offers a systematic approach for addressing
key evaluation methodology issues that have been usefully
summarized by the seminal Lewin Group report (27). These
issues have been identified as technological maturity, focus
of evaluation, perspective of evaluation, comparator, random-
ization, and time horizon. Table 1 defines each of these issues
in turn, along with an example of how they are addressed in
current telemedicine evaluation studies and how simulation
can offer a potential solution to these challenging issues.
From Table 1, it can be seen that current telemedicine
evaluations largely fail to address the broader organizational,
clinical, and social processes that new technology impacts
upon. Some evidence that exists suggests that this is a crit-
ical issue and that the focus of the evaluation may be too
narrow. For example, Lehoux et al. (17) found that the use
of telemedicine did not fit into clinicians’ communication
routines of consultation and referral. We suggest that a more
fruitful direction for the evaluation of telemedicine is to fo-
cus on the patient pathway. The patient pathway includes all
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the clinical routines (or processes) into which telemedicine
is placed, so that it can be assessed on how it sustains or
supports variation in clinical practice.
SIMULATING THE PATIENT PATHWAY
Patient pathways are tools that assist in providing general
guidelines of care for dealing with individuals and groups
of patients suffering from a wide variety of diseases. How-
ever, the majority of studies focused on traditional patient
pathways (23). The introduction of telemedicine, however,
offers a new pathway to care, although the impacts of it
are even less well understood. To this end, simulation is
put forward as a method of modeling pathways that cap-
ture the timeline of care from the start to the journey’s
end.
Discrete-Event Simulation Technique
Discrete-event simulation (DES) offers many features to cope
with understanding the complex nature of health care sys-
tems, of which the patient pathway is a clear example. There
are three critical steps to the technique that are advanta-
geous for representing pathways, which can be described
as follows: (i) Understanding the system or process to be
modeled—this is in terms of its main entities (e.g., patients),
events (e.g., clinic visits), and decisions (e.g., referral of
patient for consultation) and must be achieved for the sub-
sequent model building to have a good representative basis;
(ii) Changing the parameters of the model (e.g., time and
cost)—this step can suggest (based on mathematical distri-
butions) the optimum capacity of the system in the present
and for the future given different scenarios; and (iii) Under-
standing the inter-relationships between different entities,
events, and decisions in the system—this step can identify
the interdependencies of variables and the effect of changing
one has upon another.
The simulation’s significant feature is its capability of
performing “what if. . . ” type analyses through the manip-
ulation of variables to understand the inter-relationships
within the model and, hence, the real system. This iterative
nature to the modeling process brings about the identification
of the optimum system setup. Although simulation is not
intended to replace current designs of evaluation studies,
acceptance of any new approach to studying health care
problems needs to be justified on the professed benefits of
the proposed solution option.
Benefits of Simulating the Patient Pathway
Whereas simulation has the potential to overcome many of
the problematic issues in telemedicine evaluation (as shown
in Table 1), the true value of the approach rarely has been
realized, given the narrow focus to which it has been applied
previously, typically hospital scheduling problems (11). This
quantitative view of simulation modeling—as a way of calcu-
lating outcomes—has often failed to produce results that can
be readily implemented in real-life applications. Moreover,
the telemedicine literature, in particular, reveals a paucity
of studies that have undertaken any simulation, except for
perhaps two notable examples (6;18). The impetus, there-
fore, clearly exists for a debate on the conceptual issues of
research in telemedicine, given the problems with current
evaluation techniques (4). Robinson (24) has called for a de-
bate on simulation study as a mode of practice in various
domains. We contend that this debate is necessary within
health care and propose that a starting point for this discus-
sion is on evaluating telemedicine from a simulation of the
patient pathway.
Patient pathways do not physically exist; therefore,
methods of computerizing pathways have demonstrated
some degree of success (7). The understanding that is gained
through simulation is of a greater value than the pure numer-
ical values produced. We propose, therefore, that simulation
be viewed as a tool not to calculate outcomes but to appre-
ciate them. This difference is subtle yet powerful. In this
manner, the use of simulation will crucially serve to elicit
the intangibles, such as insight into the way the system actu-
ally operates, understanding the variables that can affect the
system, and informing decisions concerning the system and
their possible consequences.
The benefits of simulating patient pathways are in-
creased when qualitative investigations (e.g., interviews, ob-
servations, and so on) are directed at critical points along the
pathway so as to supplement the models and understand more
holistically the relationship between the interpersonal (e.g.,
patient satisfaction) and technical aspects of telemedicine (9).
For example, to return to the three key measures discussed
earlier, in diagnostic accuracy, a control patient group can be
simulated to compare the outcomes of consultations with a
clinical trial group. This approach has been shown previously
to provide an educational benefit for informing clinical deci-
sion making (14). Furthermore, cost-effectiveness measures
can also be extended to produce cost per quality measures
of outcome in terms of the quality adjusted life years for
specific health care interventions (10). This can have an im-
portant personal benefit, particularly for the patient in terms
of establishing the relationship between their illness and the
likelihood of health care saving their life. Moreover, incorpo-
rating patient satisfaction measures is possible by converting
patient responses into an appropriate numerical scale and ap-
plying these figures to the model. This strategy can have a
behavioral benefit in being able to determine fluctuations in
patient satisfaction and pinpointing problem areas.
Telemedicine Patient Pathway:
An Illustration
To illustrate the potential of simulating patient pathways,
leg ulcer sufferers were selected as case examples, given
the access to patients who have followed a traditional
138 INTL. J. OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 22:1, 2006
Evaluating telemedicine
start
Patient visits GP
Decide on
tests to be
performed
More tests
required
Referral
required?
Refer to
consultant
no
yes
Visit consultant
Blood test at clinic Doppler test atclinic
Photographs at
clinicyes
Repeat visits to
GPno Ulcer healed?
no
stop
yes
Traditional
Telelink
consultation
telelink
Tests
Process continues beyond
this point
Telelink or
traditional?
Figure 1. Leg ulcer patient pathway.
and telemedicine patient pathway. Figure 1 is a graphic
representation of part of a leg ulcer patient pathway. Informa-
tion to structure the pathway and its critical variables is col-
lected from patient records and interviews with doctors and
nurses. Figure 1 serves to illustrate all the health care events
along this section of the pathway, for instance a tele-link
consultation and the relationships between them. Figure 2
illustrates how identical patients can be treated through two
systems, both traditional and telemedicine (the timescale for
which is provided for illustrative purposes only).
Variables at strategic decision points along the path-
way control the flow of patients. These variables alter based
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1.    Patient volume – the number of patients arriving at the surgery are 
       established in order to determine the capacity that the system
       currently deals with and how this affects the system.
2.    Patient attributes – age, severity of condition, and general health
       were key issues used in clinical decision-making. These were all
       rated on a scale of 1-3 (with 1 being the youngest/least severe and
       3 being the oldest/most severe).
TESTS AT CLINIC (and PRE-SURGERY TESTS)
1.    Costs of tests – this variable is dependent on patient attributes
       (i.e., the more severe cases will need more tests). It is also
       dependent on time as if the period in between testing at the clinic
       and pre-surgery is short then only one set of tests will be needed,
       otherwise they may have to be repeated.
2.    Costs of dressings – this variable is dependent  on time, as
       dressings have to be changed twice a week, during the course of
       treatment.
3.    Time –  every event has a time delay, which may vary depending
       on patient attributes, whether telemedicine is involved, or the
       number of tests conducted.
Figure 2. Comparison of a traditional and telemedicine leg ulcer patient pathway.
on data parameters (patient volume), patient attributes (age,
severity of condition, and general health), and time, which
were deemed important for the treatment of leg ulcers
from interviews with clinical staff. These variables can be
further manipulated to determine different levels of effect
when changing sections of the process (i.e., introducing
telemedicine).
DISCUSSION AND CONCLUSIONS
This study has discussed simulation modeling—solely as a
mode of practice—for the evaluation of telemedicine in the
context of the patient pathway, as illustrated by Figures 1
and 2. Future work will need to computerize the pathway
into a dynamic running simulation model by comparing the
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predicted flow of patients with the actual flow along the
traditional and telemedicine pathway. This approach will
allow the capture of the long-term and organizational im-
pacts of telemedicine implementation. An integral part of the
discussion on the potential use of simulation has been the
focus on the patient pathway. This focus has provided a com-
pelling example of the importance of evaluating telemedicine
in the context of the health care processes into which it is
placed. A spotlight on pathways vivifies the collective bene-
fits of simulation that have been put forward by highlighting
how telemedicine can be evaluated in relation to the entities,
events, and decisions involved in the delivery of care that
it impacts upon. On the surface, telemedicine might appear
to offer a fast-track system for patients, which can reduce
the costs of dressing for leg ulcer patients, for example (as
shown in Figure 2). However, Phipps (22) provides a caveat
to this in stating that it is important that we understand how
optimizing one section of a process (e.g., introducing a tele-
link) can affect another section further along in the system
and potentially induce a bottleneck (e.g., at the surgery stage)
given that this section of the process will not have changed.
It is suggested that a new challenge for telemedicine eval-
uation studies is to compile a more comprehensive view of
the technology, in looking across multiple aspects of health-
care processes to provide a much-needed commentary on the
outcomes of health care and its delivery. To this end, pa-
tient pathway simulation has been introduced as a potential
evaluation tool for telemedicine to continually monitor clini-
cal practice, the effects of telemedicine, and changing health
outcomes.
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